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Background: Fragility fractures are important in public health because of the increase of morbidity,
mortality and cost worldwide. Most fragility fractures occur in patients who have no osteoporosis, but
the association with frailty syndrome and cerebrovascular disease is stronger. The main purpose of this
study was to evaluate comorbid conditions associated with elderly medical inpatients admitted to the
Geriatric Evaluation and Management Unit with existing fragility fractures.
Methods: This was a retrospective study screening all medical records of patients admitted to the
Geriatric Evaluation and Management Unit of a tertiary medical center from March, 2010 to April, 2011.
Patients who had bone mineral density examinations of the hips in the past 5 years were enrolled.
Pathological fractures or fractures caused by major trauma were excluded. Demographic characteristics,
such as age, sex, height, weight, body mass index, bone mineral density, underlying comorbidity, blood
biochemistry, and fracture sites were carefully recorded.
Results: Overall, 169 patients (mean age: 84 years, range: 66e96 years; 62.1% male) were enrolled, and
fragility fractures were identiﬁed in 130 patients, including 115 vertebral fractures, 12 hip fractures and
three pelvic fractures. Patients with existing fragility fractures were signiﬁcantly lower in T score
(2.33  1.10 vs. 1.87  1.23, p ¼ 0.030), serum albumin (3.6  0.4 mg/dL vs. 3.9  0.4 mg/dL,
p ¼ 0.003), total protein (6.4  0.9 mg/dL vs. 6.9  0.7 mg/dL, p ¼ 0.007), blood urea nitrogen
(20.4  11.6 mg/dL vs. 26.3  13.9 mg/dL, p ¼ 0.014), and creatinine (1.0  0.6 mg/dL vs. 1.4  0.7 mg/dL,
p < 0.001), but not in bone mineral density (0.59  0.25 g/cm3 vs. 0.66  0.16 g/cm3, p ¼ 0.120) and
diagnosis of osteoporosis (41.5% vs. 25.6%, p ¼ 0.073). A multivariate logistic regression model showed
that serum levels of albumin<3.5 mg/dL (odds ratio: 4.6, 95% conﬁdence interval: 1.1e18.2, p ¼ 0.032)
and creatinine <0.8 mg/dL (odds ratio: 10.8, 95% conﬁdence interval: 1.2e97.3, p ¼ 0.033) were signif-
icantly associated with existing fragility fractures.
Conclusion: For medical patients, fragility fractures were signiﬁcantly associated with low serum levels of
albumin and creatinine, which may be suggestive of malnutrition and low muscle mass. A further
prospective study is needed to clarify the sequential effect of fragility fracture, malnutrition and
sarcopenia.
Copyright  2012, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
Open access under CC BY-NC-ND license.LLC.1. Introduction
Fragility (or low-energy trauma) fracture is of great importance
to public health because of the association with increased
morbidity, mortality and cost worldwide.1 The estimated incidenceGerontology, Taipei Veterans
.
).
linical Gerontology & Geriatrics. Pof hip fractures in Taiwan is 225 per 100,000 persons in men and
505 per 100,000 persons in women aged 50 years, and 60% of hip
fractures are caused by low-energy injuries.2 Risk factors of fragility
fracture have been reported extensively, including older age, prior
or family history of fracture, current smoker, user of alcohol or
glucocorticoids, rheumatoid arthritis, or low bone mineral density
(BMD).3 Several predictive models have also been developed to
predict the risk of fragility fracture by combination of different risk
factors,3e6 and several guidelines have been developed to prevent
fragility fractures.7,8ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
Comparisons of demographic characteristics and laboratory data between patients
with and without existing fragility fractures.
Variables Fragility
fracture (þ)
n ¼ 130 (%)
Fragility
fracture ()
n ¼ 39 (%)
P
Age (years) 83.9  5.6 83.3  6.3 0.582
Male gender 78 (60.0) 27 (69.2) 0.349
Height (cm) 157.1  10.2 160.8  6.9 0.146
Weight (kg) 55.6  12.4 56.2  10.9 0.838
Body mass index (kg/m2) 22.5  4.6 21.7  3.6 0.464
Bone mineral density (g/cm3) 0.592  0.247 0.658  0.160 0.120
T-score 2.328  1.103 1.874  1.233 0.030*
Osteoporosis 54 (41.5) 10 (25.6) 0.073
Charlson comorbidity index 2.5  1.7 2.3  2.2 0.734
Underlying diseases
CAD 28 (21.5) 8 (20.5) 1.000
CHF 21 (16.2) 8 (20.5) 0.628
Arrhythmia 13 (10.0) 5 (12.8) 0.617
Depression 42 (32.3) 9 (23.1) 0.323
CVA 32 (24.6) 8 (20.5) 0.672
Dementia 43 (33.1) 11 (28.2) 0.696
Parkinsonism 20 (15.4) 3 (7.7) 0.292
COPD 20 (15.4) 5 (12.8) 0.802
Type 2 DM 28 (21.5) 8 (20.5) 1.000
Solid tumor 22 (16.9) 7 (17.9) 1.000
Laboratory parameters
Hemoglobin (g/L) 11.8  1.7 12.3  1.4 0.104
Albumin (mg/dL) 3.6  0.4 3.9  0.4 0.003*
Total protein (mg/dL) 6.4  0.7 6.9  0.7 0.007*
Triglyceride (mg/dL) 80.5  39.8 88.5  55.1 0.373
Total cholesterol (mg/dL) 163.0  32.2 175.5  37.3 0.074
Corrected Calcium (mg/dL) 9.11  0.42 9.06  0.43 0.679
Blood Urea Nitrogen (mg/dL) 20.4  11.6 26.3  13.9 0.014*
Creatinine (mg/dL) 1.02  0.56 1.43  0.71 <0.001*
Phosphate (mg/dL) 3.28  0.58 3.22  0.65 0.716
*p < 0.05
Abbreviations: CAD: coronary arterial disease; CHF: congestive heart failure; COPD:
chronic obstructive pulmonary disease; CVA: cerebrovascular accident; DM: dia-
betic mellitus.
Table 2
Independent risk factors for existing fragility fractures among medical inpatients.
Variables Odds ratio 95% Conﬁdence Interval P
Age 0.925 0.811-1.055 0.246
Male 0.547 0.012-10.657 0.547
Body mass index (kg/m2) 1.127 0.950-1.337 0.172
Osteoporosis vs. normal BMD 11.105 0.321-383.965 0.183
Osteopenia vs. normal BMD 2.740 0.543-13.837 0.222
Serum albumin < 3.5 mg/dL 4.547 1.137-18.178 0.032
Serum creatinine < 0.8 mg/dL 10.835 1.207-97.298 0.033
BMD: bone mineral density.
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preventable and deserves aggressive treatment for patients with
fragility fractures as the secondary prevention strategy.7,8 Diagnosis
of osteoporosis is heavily dependent on dual X-ray absorptiometry
(DXA) bymeasurement of BMD,9 but BMD is not the only predictive
factor for fragility fractures. Clinically, patients may be considered
osteoporotic if they have fragility fractures, with or without BMD
measurements. It has been reported that most fragility fractures
occur in patients who do not meet the diagnostic criteria of oste-
oporosis, but are clearly associated with frailty syndrome, cere-
brovascular disease and other conditions.10 The main purpose of
this study was to evaluate comorbid conditions associated with
elderly medical inpatients admitted to the Geriatric Evaluation and
Management Unit (GEMU) with existing fragility fractures.
2. Methods
2.1. Study subjects
This was a retrospective study collecting all records of patients
admitted to the GEMU of Taipei Veterans General Hospital from
March 1, 2010 to April 30, 2011. Overall, data of 590 elderly patients
(682 admissions) during the study period were screened, and those
who had DXA hip examinations in the past 5 years were enrolled
for analysis. A decrease in vertebral height of >20% on lateral T-L
spine X-ray ﬁlm was interpreted as positive for compression frac-
ture, as previously described.11 Pathological fractures or fractures
caused by major trauma were excluded from the study. Demo-
graphic characteristics such as age, sex, height, weight, body mass
index, BMD, underlying comorbidity, blood biochemistry, and
fracture sites were carefully recorded.
2.2. Measurement of BMD
DXA was performed by DPX-L machine (Lunar Radiation
Corporation, Madison, WI, USA), and the results were transformed
into T scores. Status of osteoporosis was determined by T score:
>1, normal; between 1 and 2.5, osteopenia; and >2.5,
osteoporosis, according to the criteria of the World Health Orga-
nization released in 2008.9
2.3. Statistical analysis
Continuous variables in the text and tables were expressed as
mean  standard deviation, and categorical variables were
expressed as percentages. All analyses were performed with SPSS
for Windows, version 17.0 (SPSS, Inc. Chicago, IL, USA). Compari-
sons of categorical variables were done by c2 test or Fisher’s exact
test; comparisons of continuous variables were done by indepen-
dent Student’s t test or ManneWhitney U test when appropriate.
For all tests, a two-tailed p value <0.05 was considered statistically
signiﬁcant.
3. Results
Overall, 169 patients (mean age: 84 years, range: 66e96 years;
62.1% male) were enrolled. Fragility fractures were identiﬁed in 130
patients, including 115 vertebral fractures, 12 hip fractures and
three pelvic fractures. Table 1 summarizes comparisons of demo-
graphic characteristics between patients with and without fragility
fractures. Patients with existing fragility fractures were signiﬁ-
cantly lower in T score (2.33  1.10 vs. 1.87  1.23, p ¼ 0.03),
serum albumin (3.6  0.4 mg/dL vs. 3.9  0.4 mg/dL, p ¼ 0.003),
total protein (6.4  0.9 mg/dL vs. 6.9  0.7 mg/dL, p ¼ 0.007), blood
urea nitrogen (20.4  11.6 mg/dL vs. 26.3  13.9 mg/dL, p ¼ 0.014),and creatinine (1.0  0.6 mg/dL vs. 1.4  0.7 mg/dL, p < 0.001), but
there was no signiﬁcant difference in BMD (0.59  0.25 g/cm3 vs.
0.66  0.16 g/cm3, p ¼ 0.120) and diagnosis of osteoporosis (41.5%
vs. 25.6%, p ¼ 0.073). A multivariate logistic regression model
showed that serum levels of albumin <3.5 mg/dL (odds ratio: 4.6,
95% conﬁdence interval: 1.1e18.2, p ¼ 0.032) and creatinine
<0.8 mg/dL (odds ratio: 10.8, 95% conﬁdence interval: 1.2e97.3,
p ¼ 0.033) were signiﬁcantly associated with existing fragility
fractures (Table 2).
4. Discussion
The occurrence of fragility fractures is usually multifactorial and
requires complex care after incident events.12 The association
between osteoporosis and fragility fractures is controversial
because fragility fracture patients are often not osteoporotic when
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patients with or without fragility fractures. Although DXA has been
the most important screening and diagnostic instrument for oste-
oporosis, it is more important to take an integrated approach to
assess fracture risks.7,8,13e15 It has generally been agreed that pre-
venting fragility fracture and its adverse outcomes is more impor-
tant than merely treating low BMD.7,14e15 Evidence supporting the
association between osteoporosis and fragility fractures has come
mainly from postmenopausal women,16 but 62.1% of the present
study patients were male. Moreover, all BMD results in the present
study were acquired from DXA hip examinations, but the most
common type of fragility fracture was vertebral. The lack of asso-
ciation between BMD and fragility fractures in our study may be
partly attributed to the location differences between fracture and
examination sites.11
We clearly identiﬁed patients with existing fragility fractures
who had signiﬁcantly lower serum levels of albumin. Serum
albumin is not only an acute phase protein in inﬂammation, but
also an indicator of protein malnutrition and sarcopenia.17e19
Protein malnutrition is not uncommon in the elderly population,
and is associated with greater bone loss, lower BMD, and muscular
wasting.19,20,21 Furthermore, chronic inﬂammation status may have
an adverse impact on bone remodeling and decrease the strength of
bony microstructure.22e24 By contrast, patients suffering from
fragility fractures may also lose their normal dietary intake due to
pain and disability. In this study, we also found that existing
fragility fractures were signiﬁcantly associated with lower serum
levels of creatinine. The association of chronic renal insufﬁciency
and osteoporosis has been well recognized, which also increases
the risk of falls and fractures.25,26 However, in the present study,
low serum levels of creatinine were highly suggestive of the
possibility of decreased muscle mass in elderly patients, especially
in those whose serum creatinine level was <0.8 mg/dL.27,28 For all
study patients, comparison of estimated glomerular ﬁltration rate
between those with and without existing fragility fractures was not
statistically signiﬁcant, which supports the idea that low serum
levels of creatinine are linked to sarcopenia.
There were several limitations in our study. First, patients were
admitted to the GEMU not because of fractures, but mainly for
various medical conditions accompanied by functional decline.
However, the main purpose of this study was to evaluate comorbid
conditions of elderly patients with existing fragility fractures.
Second, the medication and intervention for osteoporosis were not
included in this study because of the retrospective design. Third,
due to the retrospective design, no causal relation could be estab-
lished between fragility fractures, malnutrition and sarcopenia.
Malnutrition and sarcopenia may precede the occurrence of
fragility fractures but may also be a consequence of fragility
fractures.
In conclusion, for medical patients admitted to the GEMU of
a tertiary medical center in Taiwan, coexistence of fragility frac-
tures, malnutrition and sarcopeniawas common, but measurement
of BMD did not differ signiﬁcantly between patients with and
without existing fragility fractures. A further prospective study is
needed to clarify the sequential effect of fragility fracture, malnu-
trition and sarcopenia.References
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